GlassScriptPhysician profile
Abraham Ishaaya
NPI 1912959925
$41,015.17
in general payments reported to CMS, 2019-2025
72 companies · $21K in 2025
The $21K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,228 · 2020: $1,874 · 2021: $4,127 · 2022: $3,855 · 2023: $3,646 · 2024: $3,598 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $10K · Travel and Lodging: $2,050 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,147.00 |
| Food and Beverage | $10,484.94 |
| Travel and Lodging | $2,050.11 |
| Education | $247.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18,520.84 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $3,328.51 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Harmony Biosciences LLC | $1,960.61 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $1,096.34 | 2019-2025 | Xywav |
| Amgen INC. | $1,059.86 | 2019-2025 | Tezspire, Repatha, Otezla |
| Regeneron Healthcare Solutions, INC. | $1,055.50 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,032.94 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Hill-Rom Services, INC | $875.00 | 2021 | |
| Glaxosmithkline, LLC. | $728.63 | 2019-2025 | Nucala, Trelegy Ellipta |
| Electromed, INC. | $725.06 | 2022-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $685.36 | 2019-2025 | |
| Mylan Specialty L.P. | $654.64 | 2019-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $654.45 | 2020-2025 | Acthar |
| Biofire Diagnostics, LLC | $648.81 | 2019 | |
| Insmed, INC. | $629.45 | 2022-2025 | Arikayce, Brinsupri |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $460.11 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Lilly USA, LLC | $430.92 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Grifols USA, LLC | $406.48 | 2019-2024 | Prolastin-C Liquid |
| Genentech USA, INC. | $390.44 | 2019-2024 | Xolair |
| Novo Nordisk INC | $358.01 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
| Sunovion Pharmaceuticals INC. | $353.12 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $330.77 | 2019-2025 | Winrevair, Pifeltro, Zerbaxa |
| Pulmonx Corporation | $327.90 | 2022-2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Bayer Healthcare Pharmaceuticals INC. | $309.26 | 2019-2025 | |
| Amarin Pharma, INC. | $303.40 | 2019-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $286.73 | 2023-2025 | Lumryz |
| Verona Pharma, INC. | $284.60 | 2025 | Ohtuvayre |
| Optinose US, INC. | $251.33 | 2020-2022 | |
| Gilead Sciences, INC. | $211.06 | 2019-2022 | |
| Pfizer INC. | $197.11 | 2019-2024 | |
| Advanced Respiratory, INC | $184.88 | 2019-2021 | |
| Baxter Healthcare | $184.49 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inspire Medical Systems, INC. | $184.09 | 2024 | Inspire |
| Eisai INC. | $182.30 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $141.91 | 2020-2024 | Nuzyra |
| Abbvie INC. | $137.13 | 2021-2022 | |
| Philips North America LLC | $120.84 | 2020-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Ani Pharmaceuticals, INC. | $91.82 | 2023-2025 | Purified Cortrophin Gel |
| Itamar Medical INC | $89.75 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $86.74 | 2020-2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $84.63 | 2022 | |
| Sun Pharmaceutical Industries INC. | $75.71 | 2019-2022 | |
| Allergan, INC. | $64.34 | 2019 | |
| Shionogi INC | $63.57 | 2020-2024 | Fetroja |
| Takeda Pharmaceuticals U.S.A., INC. | $62.73 | 2024-2025 | Glassia |
| Idorsia Pharmaceuticals US INC | $51.60 | 2022-2023 | Quviviq |
| Qol Medical, LLC | $46.78 | 2021-2023 | Sucraid |
| Axsome Therapeutics, INC. | $41.09 | 2023-2025 | Sunosi |
| Nestle Healthcare Nutrition INC. | $40.68 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $37.53 | 2023-2024 | Linzess |
| Hikma Pharmaceuticals USA | $37.14 | 2024-2025 | Ryaltris |
| Sanofi Pasteur INC. | $34.82 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.90 | 2019 | |
| Alnylam Pharmaceuticals INC. | $31.98 | 2021 | |
| Circassia INC. | $30.82 | 2019 | |
| Viiv Healthcare Company | $26.07 | 2019 | |
| Sk Life Science, INC. | $25.04 | 2021 | |
| Viatris Specialty LLC | $24.01 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $22.85 | 2020 | |
| Mallinckrodt Enterprises LLC | $22.16 | 2019 | |
| Biogen, INC. | $20.92 | 2021 | |
| Linus Health, INC. | $20.01 | 2022 | |
| United Therapeutics Corporation | $19.63 | 2023 | Tyvaso |
| Tetraphase Pharmaceuticals, INC. | $19.35 | 2019 | |
| Heartflow, INC. | $18.69 | 2023 | Ffrct |
| Optos, INC. | $16.34 | 2020 | |
| Tanabe Pharma America, INC. | $14.95 | 2022 | |
| Exact Sciences Corporation | $14.94 | 2023 | Cologuard Collection Kit |
| G Medical Diagnostic Services, INC. | $14.47 | 2022 | |
| Redhill Biopharma INC. | $14.37 | 2020 | |
| Dexcom, INC. | $12.26 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Ishaaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.